OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Amgen/  US0311621009  /

IEX
8/17/2022  3:36:14 PM Chg. -2.61 Volume Bid3:36:39 PM Ask3:36:39 PM Market Capitalization Dividend Y. P/E Ratio
250.54USD -1.03% 2,855
Turnover: 715,172.89		 250.23Bid Size: 200 250.68Ask Size: 100 135.42 bill.USD 2.78% 24.48
TeleTrader 8/4 Amgen's Q2 EPS triples to $2.45
TeleTrader 8/4 US closes mostly lower after labor market data
TeleTrader 8/4 US opens mostly flat after trade, jobs data
TeleTrader 6/2 Wall Street opens lower amid data
GlobeNewswire 3/25 U.S. Naval Academy Announces 2021 Distinguished Graduate Awardees
GlobeNewswire 3/23 CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of Directors
GlobeNewswire 3/23 OcyonBio Client Biosimilar Solutions, Inc. Initiates Registrational Clinical Trial for Its First Bio...
GlobeNewswire 3/21 Vivacitas Oncology Appoints Harvard Professor of Medicine Dr. David Reardon, MD to the Company's Neu...
GlobeNewswire 3/21 Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire 3/17 CytomX Therapeutics to Present Updated Preclinical Data for Conditionally Activated Cytokine Program...
GlobeNewswire 3/16 C4 Therapeutics Appoints Utpal Koppikar to Board of Directors
GlobeNewswire 3/15 Molecular Partners Reports Corporate Highlights From Q4 2021 and Key Financials for Full Year 2021
GlobeNewswire 3/15 Coherus BioSciences Appoints Rosh Dias, MD, MRCP, Chief Medical Officer
GlobeNewswire 3/15 Epygenix Therapeutics Announces Appointment of Darren Cline as CEO
GlobeNewswire 3/14 OcyonBio Announces Biosimilar Solutions to Begin GMP Manufacturing in Puerto Rico
GlobeNewswire 3/9 Sensei Biotherapeutics Appoints William Ringo, MBA, as Chair of Board of Directors
GlobeNewswire 3/8 Entera Bio Reports Financial Results for the Year Ended December 31, 2021
GlobeNewswire 3/7 Dr. Gerard Blobe, M.D., Ph.D., Joins Vivacitas Oncology's Solid Tumor Medical Advisory Board
GlobeNewswire 3/3 IO Biotech Announces Appointment of David V. Smith to its Board of Directors
GlobeNewswire 3/3 Entera Bio to Report Business and Financial Results for the Year Ended December 31, 2021 on March 8,...
GlobeNewswire 3/2 AmMax Bio Announces Positive Phase 2 Results Demonstrating Proof-of-Concept for the Novel Local Deli...
GlobeNewswire 3/1 CytomX Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Busine...
GlobeNewswire 3/1 Fight Colorectal Cancer is demanding MORE from Congress this March
GlobeNewswire 3/1 Crinetics Pharmaceuticals Expands Executive Team with Appointment of James Hassard as Chief Commerci...
GlobeNewswire 2/28 Revolution Medicines Reports Fourth Quarter and Year-End 2021 Financial Results and Update on Corpor...